Health Update

Sutent no better than Xeloda in treating breast cancer

Sutent no better than Xeloda in treating breast cancer Pfizer Inc (PFE. N) stopped a late-stage study of its drug Sutent. This study was evaluating effect of this drug on advanced breast cancer patients. Sutent is presently approved to treat kidney cancer and a type of gastrointestinal cancer. Company officials notified that three other Phase III trials and two mid-stage trials of Sutent are under way in advanced forms of the cancer.

Researchers were analyzing whether patients taking Sutent could survive longer than patients receiving Xeloda.

2 million pounds of pistachios recalled under salmonella suspicion

2 million pounds of pistachios recalled under salmonella suspicion  The recent case of contaminated pistachios shows the void in food testing laws. Setton Farms in Terra Bella, California, the second-largest pistachio processor in the United States, recalled 2 million pounds of pistachios that may have been contaminated with salmonella.

Medical Care Should Not Be Affected Due To Ego Clashes: HC

Medical Care Should Not Be Affected Due To Ego Clashes: HC In response to a letter alleging carelessness by an AIIMS doctor, the Delhi High Court said on Tuesday that internal clashes at the hospital would not to be tolerated at the cost of those suffering.

Showing worry over the physicians not performing their responsibilities appropriately, the bench headed by Chief Justice A P Shah said, “No body should be victimised because of ego clash.”

The letter was written by Rekha, the mother of a month-old baby.

Walgreen to withdraw its 44 pharmacies from Medicaid program

Walgreen to withdraw its 44 pharmacies from Medicaid program Washington government announced that 6% reduction in Medicaid reimbursements for brand-name prescription drugs will be effective from May 1. The government is also insisting on cheaper, generic drugs for low-income Medicaid clients if available and equivalent to brand-name drugs. As a revolt against to new rule, Walgreen, one of the largest U. S. pharmacy chains has planned to withdraw 44 of its 111 pharmacies from the Medicaid program. Walgreen has track record of providing efficient service to people.

Arena falls short of standards required for FDA approval

Arena Pharmaceuticals Trails result of the experimental obesity drug by Arena Pharmaceuticals (ARNA. O) showed that the drug only helped in reducing 10 pounds. The trails results led to fall of shares of company.

Arena Pharmaceuticals said its two-year study on lorcaserin met all primary goals and showed the drug was well-tolerated by patients. The drug showed statistical significance in weight loss compared with patients on a placebo. After 12 months, patients on lorcaserin lost an average of 5.8% of body weight, or 12.7 pounds, compared with 2.2%, or 4.7 pounds, for the placebo group.

Human trails proves efficiency of "Polypill" in reducing risk of heart disease and stroke

The Polypill Recent approved efficiency of "Polypill," a cheap five-in-one pill in reducing the average person's risk of heart disease and stroke. This new pill is combination of five heart drugs -- three blood-pressure-lowering drugs, a cholesterol-lowering statin drug, and aspirin.

Research team led by Salim Yusuf, MD, of McMaster University in Hamilton, Ontario analyzed data collected from more than 2,000 people with one heart disease risk factor, such as obesity, high blood pressure, or high cholesterol.

Pages